Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1978 Jun;40(6):703–704. doi: 10.1136/hrt.40.6.703

Red cell survival after aortic valve replacement with Björk-Shiley prosthesis in presence of sickle-cell trait.

P W Wenham, G L Scott, J D Wisheart
PMCID: PMC483471  PMID: 656245

Abstract

A case of aortic valve replacement with a Björk-Shiley disc prosthesis in a patient with sickle-cell trait is presented. Six months after operation red cell survival was not significantly reduced. On theoretical and clinical grounds it is concluded that the presence of sickle-cell trait does not contribute to late postoperative haemolysis after heart valve replacement.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad R., Manohitharajah S. M., Deverall P. B., Watson D. A. Chronic hemolysis following mitral valve replacement. A comparative study of the Björk-Shiley, composite-seat Starr-Edwards, and frame-mounted aortic homograft valves. J Thorac Cardiovasc Surg. 1976 Feb;71(2):212–217. [PubMed] [Google Scholar]
  2. Björk V. O., Henze A., Carlström A. Haematological evaluation of the Björk-Shiley tilting disc valve prosthesis in isolated aortic valvular disease. Scand J Thorac Cardiovasc Surg. 1974;8(1):12–22. doi: 10.3109/14017437409129056. [DOI] [PubMed] [Google Scholar]
  3. Craenen J., Kilman J., Hosier D. M., Weinberger M. Mitral valve replacement in a child with sickle cell anemia. J Thorac Cardiovasc Surg. 1972 May;63(5):797–799. [PubMed] [Google Scholar]
  4. Crexells C., Aerichide N., Bonny Y., Lepage G., Campeau L. Factors influencing hemolysis in valve prosthesis. Am Heart J. 1972 Aug;84(2):161–170. doi: 10.1016/0002-8703(72)90330-4. [DOI] [PubMed] [Google Scholar]
  5. GRIGGS R. C., HARRIS J. W. The biophysics of the variants of sickle-cell disease. AMA Arch Intern Med. 1956 Mar;97(3):315–326. doi: 10.1001/archinte.1956.00250210061005. [DOI] [PubMed] [Google Scholar]
  6. HARRIS J. W., BREWSTER H. H., HAM T. H., CASTLE W. B. Studies on the destruction of red blood cells. X. The biophysics and biology of sickle-cell disease. AMA Arch Intern Med. 1956 Feb;97(2):145–168. doi: 10.1001/archinte.1956.00250200021002. [DOI] [PubMed] [Google Scholar]
  7. Slater S. D., Sallam I. A., Bain W. H., Turner M. A., Lawrie T. D. Haemolysis with Björk-Shiley and Starr-Edwards prosthetic heart valves: a comparative study. Thorax. 1974 Nov;29(6):624–632. doi: 10.1136/thx.29.6.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. WEINSTEIN I. M., SPURLING C. L., KLEIN H., NECHELES T. F. Radioactive sodium chromate for the study of survival of red blood cells. III. The abnormal hemoglobin syndromes. Blood. 1954 Dec;9(12):1155–1164. [PubMed] [Google Scholar]
  9. Yacoub M. H., Baron J., Et-Etr A., Kittle C. F. Aortic homograft replacement of the mitral valve in sickle cell trait. J Thorac Cardiovasc Surg. 1970 Apr;59(4):568–573. [PubMed] [Google Scholar]
  10. deLeval M. R., Taswell H. F., Bowie E. J., Danielson G. K. Open heart surgery in patients with inherited hemoglobinopathies, red cell dyscrasias, and coagulopathies. Arch Surg. 1974 Nov;109(5):618–622. doi: 10.1001/archsurg.1974.01360050016005. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES